Nevada Health Centers, a federal Qualified Community Health Center (QCHC), and Javara, a research organization, continue to bring clinical research to Nevadans.
Since 2023, in the Carson City area, NVHC has had the opportunity to conduct a total of fourteen trials, with six ongoing and currently offered at the Sierra Nevada Health Center.
According to officials, these studies involve the norovirus vaccine, oral GLP-1 for diabetics, malnutrition, heart failure prevention, hypothyroidism, and COVID.
NVHC and Javara say they’re seeking participants to join the norovirus vaccine clinical trial for the process of developing an effective vaccine to prevent this disease.
The Norovirus disease is highly contagious and comes with many symptoms. Those with weakened immune systems and certain age groups are more at risk.
According to the CDC, there are 2,500 norovirus outbreaks in the U.S. each year, and the virus is responsible for 58% of foodborne illnesses.
Organizers say clinical trials are a major step forward in developing new medications and therapies. The norovirus vaccine puts focus on reducing the impact of the disease that sickens thousands of people every year, leading to lost work productivity, school absences, hospitalizations, and more.
Anybody interested in partaking in the clinical trials will go through a pre-screening process, which will determine if they are eligible. There is no cost to participate, and patients are compensated for their time and travel, according to organizers.
Organizers also say participants may get access to new treatments before they are widely available and receive expert care from the clinical trial providers.
Anybody interested should contact Jason Elenberger by email or call the research team phone line at 775-200-9775.